Skip to main content
    P

    Procter & Gamble Company (PG)

    Official site

    CONSUMER DEFENSIVE • HOUSEHOLD & PERSONAL PRODUCTS • NYSE

    $173.14
    +3.34 (+1.97%)

    Market Cap: $393.56B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Procter & Gamble Company (PG) Earnings: Report Dates and Results

    Updated Oct 22, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Procter & Gamble Company (PG) is expected to report earnings on Jan 20, 2027. In the quarter ended Sep 30, 2026, Procter & Gamble Company reported EPS of $2.00, above the $1.89 estimate. It beat the EPS estimate in each of the last 15 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    95%(38/40)
    Avg Surprise
    +4.06%
    Streak
    15 Q

    Upcoming Estimates

    Reports Jan 20, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$1.82
    Range$1.71 - $1.89
    20 analysts
    EPS Revisions
    0
    19
    30d
    EPS Estimate DriftChange to current
    90d ago$1.88-3.4%
    60d ago$1.88-3.5%
    30d ago$1.88-3.5%
    7d ago$1.88-3.5%
    Current$1.82
    Revenue Consensus
    $22.85B
    Range$22.65B - $23.11B
    16 analysts
    Reports Apr 22, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$1.63
    Range$1.59 - $1.68
    16 analysts
    EPS Revisions
    2
    12
    30d
    EPS Estimate DriftChange to current
    90d ago$1.66-1.6%
    60d ago$1.66-1.5%
    30d ago$1.66-1.5%
    7d ago$1.65-1.2%
    Current$1.63
    Revenue Consensus
    $21.75B
    Range$21.37B - $22.04B
    12 analysts

    Next Report

    PG has an expected report date of Jan 20, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 3.2% below the $1.88 reported for the quarter ended Dec 31, 2025.

    PG Earnings Call

    The latest PG earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, PG beat 38, missed 1 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $23.28B, up 4.0% from $22.39B a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$2.00$1.89$1.85 - $2.00+5.82%Beat+0.5%194 up, 1 downOct 22, 2026$23.28B
    Jun 30, 2026$1.43$1.41$1.37 - $1.44+1.42%Beat-3.4%180 up, 2 downJul 29, 2026$21.20B
    Mar 31, 2026$1.59$1.56$1.53 - $1.58+1.92%Beat+3.2%160 up, 8 downApr 24, 2026$21.23B
    Dec 31, 2025$1.88$1.86$1.82 - $1.92+1.08%Beat0.0%150 up, 8 downJan 22, 2026$22.21B
    Sep 30, 2025$1.99$1.90$1.86 - $1.93+4.74%Beat+3.1%171 up, 9 downOct 24, 2025$22.39B
    Jun 30, 2025$1.48$1.42$1.37 - $1.45+4.23%Beat+5.7%185 up, 5 downJul 29, 2025$20.89B
    Mar 31, 2025$1.54$1.53$1.48 - $1.58+0.65%Beat+1.3%190 up, 14 downApr 24, 2025$19.78B
    Dec 31, 2024$1.88$1.86$1.82 - $1.93+1.08%Beat+2.2%220 up, 12 downJan 22, 2025$21.88B
    Sep 30, 2024$1.93$1.90$1.80 - $1.94+1.58%Beat+5.5%201 up, 2 downOct 18, 2024$21.74B
    Jun 30, 2024$1.40$1.37$1.35 - $1.41+2.19%Beat+2.2%203 up, 0 downJul 30, 2024$20.53B
    Mar 31, 2024$1.52$1.41$1.39 - $1.44+7.80%Beat+10.9%173 up, 2 downApr 19, 2024$20.20B
    Dec 31, 2023$1.84$1.70$1.62 - $1.72+8.24%Beat+15.7%194 up, 1 downJan 23, 2024$21.44B
    Sep 30, 2023$1.83$1.72$1.66 - $1.76+6.40%Beat+16.6%188 up, 1 downOct 18, 2023$21.87B
    Jun 30, 2023$1.37$1.32N/A+3.79%Beat+13.2%163 up, 0 downJul 28, 2023$20.55B
    Mar 31, 2023$1.37$1.32$1.30 - $1.34+3.79%Beat+3.0%185 up, 4 downApr 21, 2023$20.07B
    Dec 31, 2022$1.59$1.59$1.55 - $1.630.00%In line-4.2%196 up, 2 downJan 19, 2023$20.77B
    Sep 30, 2022$1.57$1.55$1.46 - $1.59+1.29%Beat-2.5%171 up, 2 downOct 19, 2022$20.61B
    Jun 30, 2022$1.21$1.23$1.19 - $1.26-1.63%Miss+7.1%190 up, 1 downJul 29, 2022$19.52B
    Mar 31, 2022$1.33$1.29$1.25 - $1.35+3.10%Beat+5.6%193 up, 2 downApr 20, 2022$19.38B
    Dec 31, 2021$1.66$1.65$1.59 - $1.69+0.61%Beat+1.2%180 up, 1 downJan 19, 2022$20.95B
    Sep 30, 2021$1.61$1.59$1.54 - $1.64+1.26%Beat-1.2%17N/AOct 19, 2021$20.34B
    Jun 30, 2021$1.13$1.09$1.04 - $1.11+3.67%Beat-2.6%18N/AJul 30, 2021$18.95B
    Mar 31, 2021$1.26$1.19$1.14 - $1.22+5.88%Beat+7.7%17N/AApr 20, 2021$18.11B
    Dec 31, 2020$1.64$1.51$1.38 - $1.58+8.61%Beat+15.5%18N/AJan 20, 2021$19.75B
    Sep 30, 2020$1.63$1.42$1.29 - $1.45+14.79%Beat+19.0%17N/AOct 20, 2020$19.32B
    Jun 30, 2020$1.16$1.01$0.94 - $1.11+14.85%Beat+5.5%18N/AJul 30, 2020$17.70B
    Mar 31, 2020$1.17$1.13$1.06 - $1.27+3.54%Beat+10.4%17N/AApr 17, 2020$17.21B
    Dec 31, 2019$1.42$1.37$1.31 - $1.41+3.65%Beat+13.6%17N/AJan 23, 2020$18.24B
    Sep 30, 2019$1.37$1.24$1.18 - $1.30+10.48%Beat+22.3%18N/AOct 22, 2019$17.80B
    Jun 30, 2019$1.10$1.05$1.02 - $1.10+4.76%Beat+17.0%20N/AJul 30, 2019$17.09B
    Mar 31, 2019$1.06$1.04$1.01 - $1.08+1.92%Beat+6.0%21N/AApr 23, 2019$16.46B
    Dec 31, 2018$1.25$1.21$1.17 - $1.24+3.31%Beat+5.0%20N/AJan 23, 2019$17.44B
    Sep 30, 2018$1.12$1.09$1.04 - $1.13+2.75%Beat+2.8%19N/AOct 19, 2018$16.69B
    Jun 30, 2018$0.94$0.90$0.86 - $0.93+4.44%Beat+10.6%19N/AJul 31, 2018$16.50B
    Mar 31, 2018$1.00$0.98$0.94 - $1.04+2.04%Beat+4.2%20N/AApr 19, 2018$16.28B
    Dec 31, 2017$1.19$1.14$1.11 - $1.16+4.39%Beat+10.2%20N/AJan 23, 2018$17.39B
    Sep 30, 2017$1.09$1.08$1.04 - $1.10+0.93%Beat+5.8%20N/AOct 20, 2017$16.65B
    Jun 30, 2017$0.85$0.78$0.74 - $0.82+8.97%Beat+7.6%19N/AJul 27, 2017$16.08B
    Mar 31, 2017$0.96$0.94N/A+2.13%Beat+11.6%N/AN/AApr 26, 2017$15.61B
    Dec 31, 2016$1.08$1.06N/A+1.89%Beat+3.8%N/AN/AJan 20, 2017$16.86B
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Jun 30, 2026 was $6.89, up 0.9% from the year before. It was $3.92 for the year ended Jun 30, 2017, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Jun 30, 2026$6.89+0.9%
    Jun 30, 2025$6.83+3.6%
    Jun 30, 2024$6.59+11.7%
    Jun 30, 2023$5.90+1.5%
    Jun 30, 2022$5.81+2.7%
    Jun 30, 2021$5.66+10.5%
    Jun 30, 2020$5.12+13.0%
    Jun 30, 2019$4.53+7.3%
    Jun 30, 2018$4.22+7.7%
    Jun 30, 2017$3.92N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 9,500 words across 18 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20269,54718
    2026Q2Jun 30, 202611,52919
    2026Q1Mar 31, 20268,13315
    2025Q4Dec 31, 20259,87618
    2025Q3Sep 30, 20259,60118
    2025Q2Jun 30, 202510,16721
    2025Q1Mar 31, 20258,91919
    2024Q4Dec 31, 202410,96118

    2026Q3 Earnings Call

    Opening remarks

    Andre Schulten CFO Good morning, everyone. Joining me on the call today are John Chevalier and Keri Cohen, our Senior Vice President of Investor Relations. I will start with an overview of results for the third quarter of fiscal '26 and then discuss our progress on near-term business interventions and longer-term transformation efforts. I'll close with guidance for fiscal '26 and then we'll take your questions. As we expected, we saw a solid acceleration in top line results in our fiscal third quarter. Bottom line results reflect the strength of the top line progress with partial offsets from incremental investments in the business and energy cost impacts from the conflict in the Middle East. Taken together, we remain on track to deliver within our guidance ranges for the fiscal year. Organic sales increased more than 3% versus the prior year. Volume increased 2 points, pricing was up 1 point and mix was flat for the quarter. We delivered broad-based growth across the business with each of our 10 product categories growing organic sales. Skin and Personal Care grew organic sales high single digits. Hair Care, Family Care and Home Care grew mid-single, Personal Health Care, Oral Care, Fabric Care, Baby Care, Feminine Care and Grooming each grew low single digits. Growth was also broad-based geographically with each of our 7 regions growing organic sales. Focus markets were up 3%. Organic sales in North America grew 4%. Volume was up 3 points, driven by improved consumption and trade inventory dynamics. We saw a benefit from base period trade inventory destocking and a modest help from a current period trade inventory increase late in the quarter, driven by Easter timing. Price/mix added a point of growth. The Europe region was up 2%, led by enterprise markets being up 6% and modest growth in focus markets, led by the U.K., Italy and Spain. Greater China organic sales grew 3%, continued growth in what remains a challenging consumer environment, Pampers and SK-II led the growth, each up double digits. Enterprise markets in aggregate grew 5% for the quarter. Latin America organic sales were up 5%, with Mexico and Brazil each up high single digits. Organic sales in Asia Pacific, Middle East, Africa enterprise region was up 4%. Global aggregate market share improved to in line with prior year with positive trends through the quarter. 26 of our top 50 category country combinations held or grew share for the quarter. On the bottom line, core earnings per share came in at $1.59, up 3% versus prior year on a currency-neutral basis, core EPS was in line with prior year.

    Frequently Asked Questions About PG

    When is Procter & Gamble Company's next earnings date?

    Procter & Gamble Company's next earnings report is expected for Jan 20, 2027.

    Did PG beat earnings estimates last quarter?

    Yes. Procter & Gamble Company reported EPS of $2.00 for the quarter ended Sep 30, 2026, above the $1.89 estimate, a 5.82% surprise.

    What EPS do analysts expect from PG next quarter?

    The consensus EPS estimate for Procter & Gamble Company for the quarter ending Dec 31, 2026 is $1.82 from 20 analysts, with estimates from $1.71 to $1.89.

    How often does PG beat earnings estimates?

    Procter & Gamble Company beat the EPS estimate in each of the last 15 quarters, with an average surprise of +3.65%.